ArticleCureus2025
A Cross-Sectional Study of Catheter-Related Bloodstream Infections in a Tertiary Care Hospital in India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Occurrence of antimicrobial-resistant, extended-spectrum beta-lactamase and carbapenemase-producing bacterial isolates from intensive care unit environment in two hospitals of Ethiopia.BMC microbiology · 2026Article
- Development of a risk prediction model for catheter-related bloodstream infection in hemodialysis patients based on identified risk factors.American journal of translational research · 2026Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesCatheter-related bloodstream infections (CRBSI) are commonly seen in critically ill patients with indwelling central venous catheters. To address CRBSI, one must know the causative microorganisms and their antimicrobial susceptibility profiles. This study aimed to identify the microbes that cause CRBSI and their antimicrobial susceptibility patterns.
methodsThis cross-sectional study was conducted at the Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India, between March 2022 and February 2023. Adult patients in the ICU with a central line and suspected CRBSI during the study period were included. Those with a bloodstream infection (BSI) prior to ICU admission were excluded. Two blood samples from peripheral veins and the lumen of a central venous catheter were collected for culture and sensitivity of the microorganisms. Chocolate agar, 5% sheep blood agar, and MacConkey agar served to culture pathogenic microbes. The VITEK 2 system (bioMérieux, Marcy-l'Étoile, France) was used to determine the pathogenic strains and perform antimicrobial susceptibility testing (AST). We used the R software (R Foundation for Statistical Computing, Vienna, Austria, version 4.4.3) to analyze the data.
resultsAmong the 84 participants, CRBSI was found in 36 (42.8%) patients. Their median age was 53.5 (45.8-65.0) years. Of those 36 patients, 25 (69.4%) were males. The most common cannulation site was the femoral vein (14, 38.9%), followed by the internal jugular vein (12, 33.3%) and the subclavian vein (10, 27.8%). The median durations of ICU stay and indwelling catheters were 23.0 (13.8-41.3) days and 16.0 (8.8-30.0) days, respectively. The most common microorganism causing CRBSI was
conclusionCRBSI among our study participants was mainly caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.